Major shareholders and management are loading up not pip traders and this right now in comparison to peers in the same space and same timeline is 50 cents. In 12 months time the company will be infront of a multi billion dollar license agreement like Aptoll on a market where there is no competition and we are the only drug. CEO even told the market last week big pharma is looking at the cardiovascular indication. In 12 months guess where the share price will be on a multi billion dollar license agreement with based off Aptoll minimum 200 million in upfront payment
The share price will do what it does but management are on the ball
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)